These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 11322773

  • 1. E2F activity is biphasically regulated by androgens in LNCaP cells.
    Hofman K, Swinnen JV, Verhoeven G, Heyns W.
    Biochem Biophys Res Commun; 2001 Apr 27; 283(1):97-101. PubMed ID: 11322773
    [Abstract] [Full Text] [Related]

  • 2. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
    Tomari K, Kumagai T, Shimizu T, Takeda K.
    Int J Mol Med; 2005 Feb 27; 15(2):253-8. PubMed ID: 15647840
    [Abstract] [Full Text] [Related]

  • 3. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
    Gewirtz DA, Di YM, Randolph JK, Jain PT, Valerie K, Bullock S, Nath N, Chellappan SP.
    Arch Biochem Biophys; 2001 Apr 15; 388(2):243-52. PubMed ID: 11368161
    [Abstract] [Full Text] [Related]

  • 4. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S.
    Cancer Res; 2001 Mar 15; 61(6):2583-91. PubMed ID: 11289135
    [Abstract] [Full Text] [Related]

  • 5. Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells.
    Huang H, Zegarra-Moro OL, Benson D, Tindall DJ.
    Oncogene; 2004 Mar 18; 23(12):2161-76. PubMed ID: 14676836
    [Abstract] [Full Text] [Related]

  • 6. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
    Gill RM, Slack R, Kiess M, Hamel PA.
    Exp Cell Res; 1998 Oct 10; 244(1):157-70. PubMed ID: 9770359
    [Abstract] [Full Text] [Related]

  • 7. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
    Haddad MM, Xu W, Schwahn DJ, Liao F, Medrano EE.
    Exp Cell Res; 1999 Dec 15; 253(2):561-72. PubMed ID: 10585280
    [Abstract] [Full Text] [Related]

  • 8. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity.
    Turley JM, Ruscetti FW, Kim SJ, Fu T, Gou FV, Birchenall-Roberts MC.
    Cancer Res; 1997 Jul 01; 57(13):2668-75. PubMed ID: 9205075
    [Abstract] [Full Text] [Related]

  • 9. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
    Kastner A, Espanel X, Brun G.
    Cell Growth Differ; 1998 Oct 01; 9(10):857-67. PubMed ID: 9790497
    [Abstract] [Full Text] [Related]

  • 10. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
    Sprenger CC, Vail ME, Evans K, Simurdak J, Plymate SR.
    Oncogene; 2002 Jan 03; 21(1):140-7. PubMed ID: 11791184
    [Abstract] [Full Text] [Related]

  • 11. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
    Hobisch A, Ramoner R, Fuchs D, Godoy-Tundidor S, Bartsch G, Klocker H, Culig Z.
    Clin Cancer Res; 2001 Sep 03; 7(9):2941-8. PubMed ID: 11555613
    [Abstract] [Full Text] [Related]

  • 12. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1.
    Alevizopoulos K, Sanchez B, Amati B.
    Oncogene; 2000 Apr 13; 19(16):2067-74. PubMed ID: 10803468
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
    Khwaja F, Djakiew D.
    Mol Carcinog; 2003 Mar 13; 36(3):153-60. PubMed ID: 12619038
    [Abstract] [Full Text] [Related]

  • 14. Control of E2F activity by p21Waf1/Cip1.
    Delavaine L, La Thangue NB.
    Oncogene; 1999 Sep 23; 18(39):5381-92. PubMed ID: 10498892
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of p21waf1 leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells.
    Li WW, Fan J, Hochhauser D, Bertino JR.
    Cancer Res; 1997 Jun 01; 57(11):2193-9. PubMed ID: 9187120
    [Abstract] [Full Text] [Related]

  • 16. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein.
    Mannervik M, Fan S, Ström AC, Helin K, Akusjärvi G.
    Virology; 1999 Apr 10; 256(2):313-21. PubMed ID: 10191196
    [Abstract] [Full Text] [Related]

  • 17. Tumor suppressor proteins as regulators of cell differentiation.
    Li ZR, Hromchak R, Mudipalli A, Bloch A.
    Cancer Res; 1998 Oct 01; 58(19):4282-7. PubMed ID: 9766653
    [Abstract] [Full Text] [Related]

  • 18. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
    Darbinian N, Gallia GL, Kundu M, Shcherbik N, Tretiakova A, Giordano A, Khalili K.
    Oncogene; 1999 Nov 04; 18(46):6398-402. PubMed ID: 10597240
    [Abstract] [Full Text] [Related]

  • 19. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
    Orjuela M, Orlow I, Dudas M, Ponce-Castañeda MV, Ridaura C, Leal C, Salazar A, Abramson D, Gerald W, Cordon-Cardo C.
    Hum Pathol; 2001 May 04; 32(5):537-44. PubMed ID: 11381373
    [Abstract] [Full Text] [Related]

  • 20. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.
    Choo CK, Ling MT, Suen CK, Chan KW, Kwong YL.
    Gynecol Oncol; 2000 Sep 04; 78(3 Pt 1):293-301. PubMed ID: 10985883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.